Global Childhood Cancer Disparities Revealed by Lancet Study
Analysis based on 7 articles · First reported Apr 02, 2026 · Last updated Apr 07, 2026
The study highlights significant disparities in childhood cancer outcomes globally, with low- and middle-income countries bearing the brunt. This could lead to increased focus and investment in healthcare infrastructure and cancer control systems in these regions, potentially benefiting pharmaceutical and medical device companies.
A global analysis published in The Lancet, based on the Global Burden of Disease 2023 study, reveals that 94% of childhood cancer deaths and 85% of new cases occur in low- and middle-income countries. In 2023, there were an estimated 377,000 new cases and 144,000 deaths worldwide. India alone reported 17,000 childhood cancer deaths, making it the 10th leading cause of death among children in the country. The study, co-ordinated by the Institute for Health Metrics and Evaluation and St. Jude Children s Research Hospital, emphasizes the urgent need for expanded investment in cancer control systems, including timely diagnosis, workforce training, and access to essential treatments like chemotherapy, surgery, and radiotherapy, particularly in resource-limited settings. Experts like Lisa Force, Pooja Babar, and Venkatraman Radhakrishnan underscore the preventable nature of most childhood cancer deaths in these regions and call for the inclusion of childhood cancer in national health policies.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard